Clinical Trial Update: Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase I study validates the cantharidin blister model in healthy volunteers as a methodological tool for studying inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Snippet

Sponsor: GlaxoSmithKline | Conditions: Inflammation | Phase 1 | Status: COMPLETED